Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19.

Lv, Xiu-He; Yang, Jin-Lin; Deng, Kai

Lv, Xiu-He; Yang, Jin-Lin; Deng, Kai.

Lv XH; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yang JL; Department of Gastroenterology & Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Deng K; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Am J Gastroenterol ; 116(5): 1099, 2021 05 01.

Article in English | MEDLINE | ID: covidwho-903039

Subject(s)

COVID-19 Drug Treatment; Jaundice; Antiviral Agents/therapeutic use; Humans; Liver; Lopinavir; Ritonavir/adverse effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Jaundice Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001043

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google